Weight loss drug tested as potential aid for alcohol issues after surgery
NCT ID NCT07223983
Summary
This small Yale University study will test if the medication semaglutide (a drug used for weight loss and diabetes) is practical and acceptable for treating alcohol use disorder in adults who have had weight loss surgery. The researchers want to see if the drug might help reduce alcohol use and support weight management in this specific group. This is an early pilot study with just 10 participants to check if this approach is worth investigating further.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale School of Medicine
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.